ProfileGDS4132 / 212504_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 76% 85% 87% 84% 80% 87% 84% 87% 88% 84% 77% 89% 87% 86% 82% 85% 86% 85% 86% 84% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101237.90476
GSM201543Muscle PCOS pioglitazone 121307.5585
GSM201544Muscle PCOS pioglitazone 161384.10787
GSM201545Muscle PCOS pioglitazone 201344.03384
GSM201829Muscle PCOS pioglitazone 231286.93680
GSM201830Muscle PCOS pioglitazon 251362.1687
GSM201831Muscle PCOS pioglitazone 271327.89284
GSM201832Muscle PCOS pioglitazone 31349.06987
GSM201833Muscle PCOS pioglitazone 41375.3588
GSM201834Muscle PCOS pioglitazone 81335.33284
GSM201835Muscle PCOS after pioglitazone 102251.75977
GSM201836Muscle PCOS after pioglitazone 122426.7389
GSM201837Muscle PCOS after pioglitazone 162350.67987
GSM201838Muscle PCOS after pioglitazone 202377.1586
GSM201839Muscle PCOS after pioglitazone 232304.67682
GSM201840Muscle PCOS after pioglitazone 252357.68385
GSM201841Muscle PCOS after pioglitazone 272352.45786
GSM201842Muscle PCOS after pioglitazone 32310.22285
GSM201843Muscle PCOS after pioglitazone 42352.70386
GSM201844Muscle PCOS after pioglitazone 82342.41984